80.17
Schlusskurs vom Vortag:
$80.90
Offen:
$80.91
24-Stunden-Volumen:
167.64K
Relative Volume:
0.47
Marktkapitalisierung:
$4.21B
Einnahmen:
$1.11B
Nettoeinkommen (Verlust:
$205.95M
KGV:
19.51
EPS:
4.11
Netto-Cashflow:
$254.64M
1W Leistung:
-4.92%
1M Leistung:
-6.34%
6M Leistung:
+3.70%
1J Leistung:
+16.55%
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Firmenname
Prestige Consumer Healthcare Inc
Sektor
Telefon
(914) 524-6800
Adresse
660 WHITE PLAINS RD., TARRYTOWN, NY
Vergleichen Sie PBH mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
PBH
Prestige Consumer Healthcare Inc
|
80.18 | 4.21B | 1.11B | 205.95M | 254.64M | 4.11 |
![]()
RGC
Regencell Bioscience Holdings Ltd
|
16.12 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
![]()
ZTS
Zoetis Inc
|
155.68 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
HLN
Haleon Plc Adr
|
10.35 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.46 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.68 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-09 | Herabstufung | Sidoti | Buy → Neutral |
2024-06-21 | Hochstufung | DA Davidson | Neutral → Buy |
2022-11-17 | Eingeleitet | Canaccord Genuity | Buy |
2022-05-10 | Hochstufung | Jefferies | Hold → Buy |
2022-05-09 | Hochstufung | Oppenheimer | Perform → Outperform |
2020-08-07 | Herabstufung | DA Davidson | Buy → Neutral |
2020-06-29 | Hochstufung | Sidoti | Neutral → Buy |
2020-04-14 | Herabstufung | Jefferies | Buy → Hold |
2020-04-07 | Fortgesetzt | Sidoti | Neutral |
2020-03-26 | Hochstufung | Jefferies | Hold → Buy |
2020-03-24 | Eingeleitet | Oppenheimer | Perform |
2020-03-19 | Hochstufung | DA Davidson | Neutral → Buy |
2019-01-15 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2017-12-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
2017-06-02 | Hochstufung | Jefferies | Underperform → Hold |
2017-05-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2016-12-27 | Bestätigt | B. Riley & Co. | Buy |
2016-11-17 | Eingeleitet | Gabelli & Co | Buy |
2016-08-12 | Hochstufung | Sidoti | Neutral → Buy |
2016-03-08 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
2016-02-05 | Eingeleitet | Piper Jaffray | Overweight |
2015-11-30 | Herabstufung | Jefferies | Hold → Underperform |
2014-04-28 | Bestätigt | B. Riley & Co. | Buy |
2014-04-28 | Bestätigt | Oppenheimer | Outperform |
2013-07-09 | Eingeleitet | B. Riley & Co. | Buy |
Alle ansehen
Prestige Consumer Healthcare Inc Aktie (PBH) Neueste Nachrichten
Zacks Research Issues Positive Forecast for PBH Earnings - Defense World
Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination - TAPinto
Little Remedies Honey Cough Syrup recalled over safety concerns - WCNC
Medtech Products Inc. Issues Nationwide Recall of Little Remedie - GuruFocus
Prestige Consumer (PBH) Recalls Little Remedies Honey Cough Syrup Amid Safety Concerns | PBH Stock News - GuruFocus
Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination - SINA HONG KONG LIMITED
Medtech Products Inc. Issues Nationwide Recall of Little - GlobeNewswire
Little Remedies Honey Cough Syrup Recalled Nationwide Due to Bacterial Risk | PBH Stock News - Stock Titan
Yousif Capital Management LLC Sells 382 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Long Term Trading Analysis for (PBH) - news.stocktradersdaily.com
5 Undervalued Semiconductor Stocks You Can Buy Now and Hold Long-Term - The Globe and Mail
Should You Continue to Hold Prestige Consumer Stock in Your Portfolio? - sharewise
Global Dental Floss Industry Report | Product Innovation Boosts - openPR.com
Those who invested in Prestige Consumer Healthcare (NYSE:PBH) five years ago are up 112% - simplywall.st
Wealth Enhancement Advisory Services LLC Grows Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Here's How Much You Would Have Made Owning Prestige Consumer Stock In The Last 15 Years - Benzinga
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer - GuruFocus
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference - The Manila Times
Prestige Consumer Healthcare Inc. to Present at the - GlobeNewswire
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and ... - Bluefield Daily Telegraph
Prestige Consumer Healthcare Fireside Chat: Strategic Insights Coming at Major Oppenheimer Conference - Stock Titan
Millennium Management LLC Trims Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today - Benzinga
Stocks in play: BCE Inc. - The Globe and Mail
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick - Yahoo Finance
Hogs Close Mixed on Monday - The Globe and Mail
Zacks Research Issues Optimistic Outlook for PBH Earnings - Defense World
Tidal Investments LLC Sells 1,380 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Equities Analysts Set Expectations for PBH Q1 Earnings - Defense World
Cetera Investment Advisers Invests $413,000 in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Is Bio-Techne Stock the Right Pick for Your Portfolio Now? - The Globe and Mail
The Sandlot Star Patrick Renna Teams Up with Dramamine® to Revisit an Iconic SceneThis Time, Puke Free - The Malaysian Reserve
Lice Treatment Market Deep Research Report Identifies Key TrendsPrestige Consumer Healthcare, Reckitt - openPR.com
Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock? - Nasdaq
Prestige Consumer Healthcare Inc. (NYSE:PBH) Holdings Decreased by Nuveen Asset Management LLC - Defense World
Deutsche Bank AG Purchases 14,929 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Prestige Consumer Healthcare Inc. (NYSE:PBH) Position Reduced by Ameriprise Financial Inc. - Defense World
Prestige Consumer Healthcare (NYSE:PBH) Upgraded to “Buy” at StockNews.com - Defense World
Weekly Recap: 14 Health Press Releases You Need to See - Yahoo Finance
Prestige's Diversified Portfolio and Strong Execution Should Drive Steady Growth Across Categories - Morningstar
Prestige Consumer Stock Up 8% Since Q4 Earnings Beat, Margin Increase - MSN
U.S. News Announces the 2025-2026 Best OTC Medicine & Health Products - Morningstar
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q4 2025 Earnings Call Transcript - Insider Monkey
US News 2025 Best OTC Products: Nature Made Leads with 7 Top Rankings in Expert Survey - Stock Titan
How To Trade (PBH) - news.stocktradersdaily.com
Prestige Consumer Healthcare’s Earnings Call Highlights Growth Amid Challenges - TipRanks
Aussie Stocks Hold Steady With US-China Trade Optimism - Finimize
Prestige Consumer Healthcare (NYSE:PBH) Cut to “Hold” at StockNews.com - Defense World
Prestige Consumer Healthcare Full Year 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Prestige Consumer Healthcare (NYSE:PBH) Stock Rating Upgraded by Royal Bank of Canada - Defense World
Jefferies raises Prestige Brands target to $85, maintains Hold rating By Investing.com - Investing.com India
Finanzdaten der Prestige Consumer Healthcare Inc-Aktie (PBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):